Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Black Diamond Therapeutics (BDTX) Leases (2020 - 2025)

Black Diamond Therapeutics' Leases history spans 4 years, with the latest figure at $9.3 million for Q4 2025.

  • For Q4 2025, Leases fell 51.06% year-over-year to $9.3 million; the TTM value through Dec 2025 reached $9.3 million, down 51.06%, while the annual FY2025 figure was $9.3 million, 51.06% down from the prior year.
  • Leases reached $9.3 million in Q4 2025 per BDTX's latest filing, down from $16.7 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $28.4 million in Q3 2021 to a low of $9.3 million in Q4 2025.
  • Average Leases over 3 years is $18.0 million, with a median of $18.2 million recorded in 2025.
  • Peak YoY movement for Leases: soared 3350.52% in 2021, then tumbled 51.06% in 2025.
  • A 3-year view of Leases shows it stood at $28.4 million in 2021, then crashed by 32.98% to $19.0 million in 2024, then crashed by 51.06% to $9.3 million in 2025.
  • Per Business Quant, the three most recent readings for BDTX's Leases are $9.3 million (Q4 2025), $16.7 million (Q3 2025), and $17.5 million (Q2 2025).